Steering Committee

The CTTI Steering Committee (SC), made up of representatives from CTTI members across multiple sectors, provides input into decisions about CTTI priorities, projects and recommendations. Below, you will find a list of our SC members:

Murray Abramson, MD
VP Global Clinical Operations
Maria Ali, MBBS, MBA
Chief Medical Officer
Jeff Allen, PhD
Executive Director
Jaime Arango, EdD, CIP
Director, CITI Educational Initiatives

CITI Program, a Division of BRANY

Jimmy Bechtel
Senior Project Manager
Elise Berliner, PhD
Director of Technology Assessment Program, Center for Evidence and Practice Improvement
David Borasky, MPH, CIP
Vice President, Quality Management
Robyn Burns, PhD
Program Manager, MRFBC; Science Officer, MRF
Jerry Call
Data Analyst and Staff Science Expert
David Ciavarella, MD
Vice President, Global Clinical Development
Linda Coleman
Director, Human Research Protection Program
Dan Cooper
Associate Vice Chancellor for Clinical and Translational Science
MarieElena Cordisco MA, NP-C, APRN, CCRC
Office of Clinical Trials, Department of Research and Innovation
Valentina Dilda
Director Experimental Medicine
Victoria Dohnal
Senior Manager, Science & Regulatory Affairs
Kristin Dolinski
Director, Science and Regulatory Advocacy
Scott Evans, PhD, MS
Harvard University, Senior Research Scientist
Gary Fanjiang, MD, MBA, MS
Executive Medical Director
Ari Feldman
Vice President, Global Compliance & Strategy
Beth Fraulo
Director of Operations for DCRI
Pat Furlong
Rodrigo Garcia, MD, MS
Head, Global Clinical Applications and Innovation, Biopharma | Global Clinical Operations
Cynthia Geoghegan
Patient/Caregiver Representative
James Gibaldi
Associate Director, Research Partnerships
Hernando Giraldo
US Regional Lead Digital Development, Global Clinical Operations
Jörg Goldhahn, MD
Medical Director of the New Bachelor in Medicine at ETH
Marie-Pierre Hellio Le Graverand-Gastineau, MD, DSc, PhD
Vice President and Head of Clinical Development and Operations, Global Product Development
Mori 'Hiro' Hiromasa
Head of Neurology Patient Technology Europe


Judith Hochman, MD
Co-Director, NYU-HHC, CTSI
Grant Huang, MPH, PhD
Deputy Director, Cooperative Studies Program, Office of Research and Development
Brenda Huneycutt
Director, Regulatory Innovation
Patricia Hurley, MSc
Director, Research and Analysis, Center for Research & Analytics (CENTRA)
Cheryl Jernigan, CPA, FACHE
Volunteer Advocate/AIS Steering Committee Member
Hallie Kassan, MS, CIP
Director, Office of the HRPP
Nicholas Kenny, PhD
Chief Scientific Officer
Jason Kim
Director Osteoarthritis Research Programs
Kerstin Koenig
Global Head Research & Development Quality at Bristol Myers Squibb
Michael Kurilla, MD-PhD
Director, Division of Clinical Innovation, NCATS
Martin Landray, PhD, FRCP
Professor of Medicine & Epidemiology; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford
Patrick Lee, MD
Xavier Lefebvre
Global Vice President
Emily Lemons
Associate Director of Quality Assurance
Joanne Less, PhD
Director, Good Clinical Practice Program
Barbara LeStage
Patient/Caregiver Representative
Michael Lincoff, MD
Director, Center for Clinical Research; Director, Cleveland Clinic Coordinating Center for Clinical Research (C5 Research)
Beverly Lorell, MD, FACC
Senior Medical & Policy Advisor
Matt Maxwell
CEO, Accel Clinical Services
Jerry Menikoff, MD, JD
Kristen Miller, PharmD
Health Science Policy Analyst, OMP
Jules Mitchel, MBA, PhD
Virginia Nido
Head, Industry Collaborations Management, Product Development, Global External Collaborations
Ingrid Oakley-Girvan, PhD, MPH
SVP of Research and Strategy
Kathryn O'Callaghan
Acting Associate Director for Science and Strategic Partnerships
Kelley O'Donoghue, MPH, CIP
Executive Director, Research Subjects Review Board
Janette Panhuis, BScN, MBA
Chief Executive Officer
Jahmeilia Paul, MPH, CHES
Manager, Patient Education
Lynne Quittell, MD
Vice Chair Data Safety Monitoring Board
James Rollins, MD
Director of the Division of Items and Devices; Coverage and Analysis Group
Daniel Rose, MD
Senior Advisor
Joshua Rose
Vice President, Head R&D Solutions Strategy
Ronenn Roubenoff, MD, MHS
Global Head, Musculoskeletal Translational Medicine
Albert T. Roy
Executive Director
Michele Russell-Einhorn, JD
Chief Compliance Officer and Institutional Official
Karlin Schroeder, MA
Associate Vice President, Community Engagement
Nicole Sheetz
Advisor, Clinical Systems & Supply Planning (CSSP) Clinical Design, Delivery & Analytics (CDDA)
Jeffrey Sherman, MD, FACP
Chief Medical Officer
Robin Weinick
Senior VP and Managing Director – Americas
Theresa Strong, PhD
Director of Research Programs
Janet Trunzo
Senior Executive Vice President
Tracy Vanderslice
Vice President of Global Clinical Sciences & Delivery
Jose Vega
Vice President, Chief Safety Officer
Kapila Viges
Executive Director
Scott Weir
Director, The Institute for Advancing Medical Innovation
Neil Weissman, MD
Tiffany Westrich-Robertson
CEO, Director of Patient Engagement
Alcia Williams, MD, MPH, Capt USPHS
Deputy Associate Director for Science, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention
Craig Wozniak
Vice President, Trial Coordination & Site Management-Americas
Jeremy Wyatt